3c09: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3c09" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3c09.png|left|200px]] | [[Image:3c09.png|left|200px]] | ||
{{STRUCTURE_3c09| PDB=3c09 | SCENE= }} | {{STRUCTURE_3c09| PDB=3c09 | SCENE= }} | ||
===Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extracellular region of EGFR=== | ===Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extracellular region of EGFR=== | ||
{{ABSTRACT_PUBMED_18394559}} | {{ABSTRACT_PUBMED_18394559}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Epidermal Growth Factor Receptor]] | *[[Epidermal Growth Factor Receptor|Epidermal Growth Factor Receptor]] | ||
*[[Monoclonal Antibody]] | *[[Monoclonal Antibody|Monoclonal Antibody]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018394559</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Homo sapiens, mus musculus]] | [[Category: Homo sapiens, mus musculus]] | ||
| Line 37: | Line 26: | ||
[[Category: Antitumor]] | [[Category: Antitumor]] | ||
[[Category: Cell surface receptor]] | [[Category: Cell surface receptor]] | ||
[[Category: Drug immune system | [[Category: Drug immune system-transferase complex]] | ||
[[Category: Fab fragment]] | [[Category: Fab fragment]] | ||
[[Category: Glycoprotein]] | [[Category: Glycoprotein]] | ||
[[Category: Immune system-transferase complex]] | |||
Revision as of 22:34, 26 July 2012
Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extracellular region of EGFR
Template:ABSTRACT PUBMED 18394559
About this Structure
3c09 is a 6 chain structure of Epidermal Growth Factor Receptor and Monoclonal Antibody with sequence from Homo sapiens and Homo sapiens, mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- Schmiedel J, Blaukat A, Li S, Knochel T, Ferguson KM. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell. 2008 Apr;13(4):365-73. PMID:18394559 doi:10.1016/j.ccr.2008.02.019